On October 18, Glytec participated in the American Diabetes Association’s 2020 Virtual Step Out Walk to Stop Diabetes. A total of 45 team members, comprised of Glytec employees, family and friends raised $6,308, making Team Glytec the #1 company team for the Boston event.
As a market leader in the diabetes space, Glytec recognizes the impact of diabetes and the importance of supporting organizations like the American Diabetes Association and their research, information and advocacy efforts.
Celebrating All Participants
The American Diabetes Association hosted a live Facebook party on October 18 that featured shout outs to top fundraisers and teams, as well as an interview with John Downey, Chief Commercial Officer at Glytec and Rachel Gibbons, Director of Development at the American Diabetes Association. Watch the video below to see their conversation.
Making a Difference, Wherever You Are
This year’s virtual event gave the opportunity for Glytec employees all across the country to come together, wherever they are located, to showcase their Team Glytec spirit and support a great cause.
Now, more than ever, people living with diabetes need our help, and we are proud to be supporting and fundraising for such an important cause.
Thank you to all of our employees who participated and all of our family and friends who donated. We look forward to coming together and walking again in 2021, either virtually or in-person.
©Copyright 2023 Glytec, LLC on behalf of Aseko, Inc. | Terms of Use | Legal Disclaimer | Privacy Policy | Contraindications, Warnings and Precautions
The eGlycemic Management System® is a modularized solution for glycemic management across the care continuum that includes Glucommander™. Glucommander™ is a prescription-only software medical device for glycemic management intended to evaluate current as well as cumulative patient blood glucose values coupled with patient information including age, weight and height, and, based on the aggregate of these measurement parameters, whether one or many, recommend an IV dosage of insulin, glucose or saline or a subcutaneous basal and bolus insulin dosing recommendation to adjust and maintain the blood glucose level towards a configurable physician- determined target range. Glucommander™ is indicated for use in adult and pediatric (ages 2-17 years) patients. The measurements and calculations generated are intended to be used by qualified and trained medical personnel in evaluating patient conditions in conjunction with clinical history, symptoms, and other diagnostic measurements, as well as the medical professional’s clinical judgement. No medical decision should be based solely on the recommended guidance provided by this software program.
Glucommander™ is only available for use in the United States.
This site is only intended for use in the United States.
Aseko is a registered trademark of Aseko, Inc.